ω‑3 fatty acids in atherosclerotic cardiovascular disease (Review)

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Atherosclerotic cardiovascular disease (ASCVD) is one of the most common chronic diseases in the world. Epidemiological evidence and clinical trials have shown that ω‑3 fatty acids have a variety of promoting effects in reducing the risk of ASCVD, but different conclusions of large randomized controlled trials make their clinical use in the prevention and treatment of ASCVD controversial. The present review focuses on the pharmacological mechanism, clinical trials and evidence value of clinical applications of ω‑3 fatty acids in order to provide theoretical and practical evidence for the clinical application strategy, and follow‑up research and development of ω‑3 fatty acids as anti‑ASCVD drugs.

This publication has 56 references indexed in Scilit: